Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial
JAMA Oncol 2020 May 21;[EPub Ahead of Print], DA Reardon, AA Brandes, A Omuro, P Mulholland, M Lim, A Wick, J Baehring, MS Ahluwalia, P Roth, O Bähr, S Phuphanich, JM Sepulveda, P De Souza, S Sahebjam, M Carleton, K Tatsuoka, C Taitt, R Zwirtes, J Sampson, M WellerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.